Thus, mutations in FBN1 and consequent deficiency in fibrillin-1, as in MFS, result not only in structural weakness of connective tissue due to impaired microfibril formation but also in dysfunctional TGF-β signaling [4,5]. This evidence concerns the gene TGFB1 and Marfan syndrome.